Key result
Frailty, sarcopenia, cachexia, and malnutrition frequently coexist in HF and are linked to poor prognosis.
Why the study?
Frailty, sarcopenia, cachexia, and malnutrition frequently overlap in patients with heart failure, making a comprehensive understanding essential for management.
Frailty, sarcopenia, cachexia, and malnutrition frequently coexist in heart failure patients and require comprehensive assessment and multidisciplinary management due to their significant adverse impact on prognosis.
Highlights overlapping frailty syndromes in HF; leaves open targeted intervention trials.
With global aging, the number of patients with heart failure has increased markedly. Heart failure is a complex condition intricately associated with aging, organ damage, frailty, and cognitive decline, resulting in a poor prognosis. The relationship among frailty, sarcopenia, cachexia, malnutrition, and heart failure has recently received considerable attention. Although these conditions are distinct, they often exhibit a remarkably close relationship. Overlapping diagnostic criteria have been observed in the recently proposed guidelines and position statements, suggesting that several of these conditions may coexist in patients with heart failure. Therefore, a comprehensive understanding of these conditions is essential, and interventions must not only target these conditions individually, but also provide comprehensive management strategies. This review article provides an overview of the epidemiology, diagnostic methods, overlap, and prognosis of frailty, sarcopenia, cachexia, and malnutrition in patients with heart failure, incorporating insights from the FRAGILE-HF study data. Additionally, based on existing literature, this article discusses the impact of these conditions on the effectiveness of guideline-directed medical therapy for patients with heart failure. While recognizing these conditions early and promptly implementing interventions may be advantageous, further data, particularly from well-powered, large-scale, randomized controlled trials, are necessary to refine personalized treatment strategies for patients with heart failure.
No takes yet. Share an insight, caveat, or question.
Maeda et al. (2024) conducted a review in Heart failure. Frailty, sarcopenia, cachexia, and malnutrition was evaluated. Frailty, sarcopenia, cachexia, and malnutrition are interrelated conditions that frequently coexist in patients with heart failure and are associated with poor prognosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: